Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 10/6/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong John Kolman?

John L. Kolman

Senior Administrator

Plexus Corp.

HQ Phone:  (920) 722-3451

Email: k***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Plexus Corp.

One Plexus Way

Neenah, Wisconsin,54956

United States

Company Description

About Plexus Corp. - The Product Realization Company Plexus (www.plexus.com) delivers optimised Product Realization solutions through a unique Product Realization Value Stream service model. This customer-focused services model seamlessly integrates innovative...more

Background Information

Employment History

Executive Director and Head of Translational Medicine

QPS, LLC


Executive Director

BioReliance Corporation


Senior Scientist

Invitrogen Corporation


Post Doc and Staff Scientist

Salk Institute


Senior Director, Research and Development

BioCoR Research


Web References(23 Total References)


Speaker/Bios « 2011 PDA Annual Meeting

pdaannualmeeting.org [cached]

John Kolman
John Kolman BioReliance Dr. Kolman joined BioReliance in April of 2008 as head of the newly formed Global Research and Development as well as the Department of Genomics. Prior to that, he was a Principal Scientist in the Corporate Research Laboratory of Invitrogen Corp. There, he built collaborations with academic thought leaders and led cross-department teams in the application of cutting edge technologies to novel, high-impact areas. John received his Ph.D from Yale University for the study of molecular events underpinning Epstein-Barr virus lytic activation. He then continued with a post-doctoral appointment at the Salk Institute, eventually rising to Staff Scientist. His career has been motivated by the study of difficult biological questions using new molecular approaches.


www.fiercebiotech.com

John Kolman, executive director and head of translational medicine at QPS, added: "As a full CRO, we must meet the needs of the large pharmaceutical and biopharmaceutical industry in a productive manner with solutions that offer robustness and confidence.


www.absciex.com

Senior Vice President, Global Head of Pre-Clinical Development, QPS, John L Kolman Ph.D., Executive Director, Head of Translational Medicine, QPS, Daniell Rowles, Ph.D., Research Scientist, Department of Translational Medicine, QPS, Suma Ramagiri, PhD., Senior Manager, Global Pharma/Biopharma/CRO Business Unit, SCIEX, Susan Zondlo, Ph.D., Associate Director, Biomarkers, Department of Translational Medicine, QPS, Graham Gibson, Sr. Sales Representative, SCIEX, Yi Zhang, Market Development Manager, AMER Pharma/Biopharma Market, SCIEX, Shaw Xia, Sr. Application Scientist, SCIEX
"As a full CRO, we must meet the needs of the large pharmaceutical and biopharmaceutical industry in a productive manner with solutions that offer robustness and confidence," said John Kolman, Executive Director and Head of Translational Medicine at QPS.


www.isbiotech.org

John L. Kolman, PhD
Independent Consultant


safclive.com

Our own John Kolman, Executive Director and Head of Genomics for BioReliance will be featured speaking at 10:45am on Day Two about the "Validation of a multiplex ADME SNP assay for clinical trial studies: The Illumina® Vera Code® ADME core panel - an alternative to DMET".


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory